Similac Advance preterm extension
This article was originally published in The Tan Sheet
Executive Summary
Abbott Labs division Ross Products to launch three preterm formulas: NeoSure Advance, Similac Special Care and Similac Natural Care. Infant formulas are fortified with docosahexaenoic and arachidonic acids, complement firm's DHA- and ARA-fortified Similac Advance for term infants. New formulas, hitting shelves this month, will compete with Mead Johnson's recently completed Enfamil LIPIL line; BMS division launched enriched Enfacare in August (1"The Tan Sheet" Aug. 26, 2002, In Brief)...
You may also be interested in...
LIPIL line complete
Enfacare LIPIL, intended for premature babies after they leave the hospital, rounds out Mead Johnson's ARA-, DHA-fortified infant formula line, BMS subsidiary announces Aug. 20. Line extension contains same levels of docosahexaenoic acid, arachidonic acid as Enfamil LIPIL preterm, term formulas, but differs in fat levels. Enfacare, which will reach shelves in late summer/early fall, is line-priced with other two LIPIL products and will retail for about 10%-15% more than original Enfacare formulas. Firm also plans to give free cases of Enfamil LIPIL with Iron to mothers who give birth on Labor Day...
There’s ‘No Silver Bullet’ For Making Medicines Packaging Sustainable
There’s no simple answer to the question of how to make medicines packaging sustainable, says international recycling consultancy and Veolia Group subsidiary Circpack. “Manufacturers need to assess what works best for them, and recyclers will do the same,” Circpack analyst and circular packaging expert Filipe Vieira de Castro tells HBW Insight in this exclusive Q&A. “The best thing we can all do is put effort into finding common ground between systems, which comes down to better understanding the complexities between them.”
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.